Introduction: We describe an interesting patient with penicillamine-induced dermopathy. Clinical Picture: A 49-year-old woman presented with a 1-year history of recurrent haemorrhagic blisters, milia and purpura over both her elbows, while on long-term penicillamine therapy (1.5 g daily) for Wilson’s disease. Histologically, dermal elastin fibres were markedly reduced in the affected areas, consistent with penicillamine-induced elastolysis. Treatment and Outcome: The patient’s lesions improved significantly after reduction of her penicillamine dose to 500 mg daily. Conclusions: The cutaneous side effects of long-term penicillamine therapy are important t
Background: Hydroxyurea is an antimetabolite primarily used to treat myeloproliferative disorders, a...
Drug induced allergic reactions can be categorized into IgE-mediated and non-IgE mediated hypersensi...
Introduction: The treatment of chronic actinic dermatitis (CAD), a sun-induced disorder characterize...
Penicillamine toxicity in Wilson’s disease has been well reported but rarely seen now as newer agent...
Long term D-penicillamine (DPA) therapy to treat Wilson disease can induce elastosis perforans serpi...
Long term use of D-penicillamine for Wilson’s disease can be associated with many adverse reactions ...
Elastosis perforans serpiginosa (EPS) is a rare complication of chronic therapy with a high-dose of ...
SuMMARY We report the case of a 48-year-old woman who developed morphea-like plaques after 1 year of...
Long term D-penicillamine therapy, especially when used to treat Wilson′s disease has been shown to...
SUMMARY A case of dermatomyositis developing during the course of treatment with D-penicil-lamine in...
Penicillamine-induced skin changes are rare and include: hypersensitivity reactions, autoimmune reac...
Introduction: Adverse reactions to medications often present with involvement of the integument. The...
Skin adverse events associated with D-Penicillamine (DPA) are common and multi-faceted, although the...
Background: Stasis dermatitis is a common clinical manifestation present with varicose vein, skin ch...
A 47 year old man presented with a two year history of increasing cervical dysphagia, dyspnoea, and ...
Background: Hydroxyurea is an antimetabolite primarily used to treat myeloproliferative disorders, a...
Drug induced allergic reactions can be categorized into IgE-mediated and non-IgE mediated hypersensi...
Introduction: The treatment of chronic actinic dermatitis (CAD), a sun-induced disorder characterize...
Penicillamine toxicity in Wilson’s disease has been well reported but rarely seen now as newer agent...
Long term D-penicillamine (DPA) therapy to treat Wilson disease can induce elastosis perforans serpi...
Long term use of D-penicillamine for Wilson’s disease can be associated with many adverse reactions ...
Elastosis perforans serpiginosa (EPS) is a rare complication of chronic therapy with a high-dose of ...
SuMMARY We report the case of a 48-year-old woman who developed morphea-like plaques after 1 year of...
Long term D-penicillamine therapy, especially when used to treat Wilson′s disease has been shown to...
SUMMARY A case of dermatomyositis developing during the course of treatment with D-penicil-lamine in...
Penicillamine-induced skin changes are rare and include: hypersensitivity reactions, autoimmune reac...
Introduction: Adverse reactions to medications often present with involvement of the integument. The...
Skin adverse events associated with D-Penicillamine (DPA) are common and multi-faceted, although the...
Background: Stasis dermatitis is a common clinical manifestation present with varicose vein, skin ch...
A 47 year old man presented with a two year history of increasing cervical dysphagia, dyspnoea, and ...
Background: Hydroxyurea is an antimetabolite primarily used to treat myeloproliferative disorders, a...
Drug induced allergic reactions can be categorized into IgE-mediated and non-IgE mediated hypersensi...
Introduction: The treatment of chronic actinic dermatitis (CAD), a sun-induced disorder characterize...